Griffiths L, Dachs G U, Bicknell R, Harris A L, Stratford I J
Experimental Oncology, Medical Research Council Harwell, Chilton, United Kingdom.
Cancer Res. 1997 Feb 15;57(4):570-2.
We report that hypoxia regulates and influences the level of the angiogenic enzyme platelet-derived endothelial cell growth factor (PD-ECGF), also called thymidine phosphorylase, in vitro and in vivo. Levels of PD-ECGF protein increased 6-fold in the breast cancer cell line MDA 231 after 16 h of growth in 0.3% oxygen. A simultaneous increase in enzyme activity was observed. Immunohistochemical staining of MDA 231 tumors grown in nu/nu mice showed increased expression of PD-ECGF in those parts of the tumor that are proximal to the areas of necrosis. In addition, increased and widespread staining for PD-ECGF protein was obtained when the tumor vascular supply was occluded for 2 h by clamping. Lowering the media pH to 6.3-6.7 in vitro also resulted in an increase in PD-ECGF protein levels. This study demonstrates that tumor microenvironmental factors can result in the specific up-regulation of an angiogenic enzyme that can also activate 5-fluorouracil prodrugs and hence is exploitable therapeutically.
我们报告称,缺氧在体外和体内均能调节并影响血管生成酶血小板衍生内皮细胞生长因子(PD-ECGF,也称为胸苷磷酸化酶)的水平。在0.3%氧气环境中生长16小时后,乳腺癌细胞系MDA 231中的PD-ECGF蛋白水平增加了6倍。同时观察到酶活性增强。对在无胸腺裸鼠体内生长的MDA 231肿瘤进行免疫组织化学染色显示,肿瘤中靠近坏死区域的部分PD-ECGF表达增加。此外,通过钳夹使肿瘤血管供应闭塞2小时后,PD-ECGF蛋白的染色增加且分布广泛。在体外将培养基pH值降至6.3 - 6.7也会导致PD-ECGF蛋白水平升高。本研究表明,肿瘤微环境因素可导致一种血管生成酶的特异性上调,该酶还能激活5-氟尿嘧啶前药,因此在治疗上具有可利用性。